Immediate release pharmaceutical formulation of 4-[3-(4- cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H- phthalazin-1-one | Patent Publication Number 20230000862
US 20230000862 A1Patent NumberUS 11633396 B2
Application Number17821833
Filled DateAug 24, 2022
Priority DateOct 7, 2008
Publication DateJan 5, 2023
Original AssigneeAstrazeneca
Current AssigneeKudos Pharmaceuticals Limited
Inventor/ApplicantsBernd Harald Liepold
Claudia Bettina Packhaeuser
Benedikt Steitz
Katja Maren Fastnacht
Kieran James Lennon
Julie Kay Cahill
Michael Karl Bechtold
Claudia Bettina Packhaeuser
Benedikt Steitz
Katja Maren Fastnacht
Kieran James Lennon
Julie Kay Cahill
Michael Karl Bechtold
Empower your practice with Patexia Publication Prosecution IP Module.
Get access to our exclusive rankings and unlock powerful data.
Looking for a Publication Attorney?
Get in touch with our team or create your account to start exploring a
network of over 120K attorneys.